Table 2 Progression free survival
Covariate(s) in model | Patients | Hazard Ratio (Pertuz vs. Control) | HR 95% CI | P value |
|---|---|---|---|---|
None | All | 0.66 | 0.30–1.47 | 0.310 |
Months from initial Dx to Met Dx | All | 0.78 | 0.35–1.76 | 0.549 |
Race | All | 0.59 | 0.25–1.38 | 0.222 |
Liver Met; interaction | Liver mets | 4.26 | 1.10–16.60 | 0.036 |
Liver Met; interaction | No liver mets | 0.11 | 0.03–0.42 | 0.001 |